130 Chapter 6 Supplementary data Appendix 1. Survey questions In which country do you currently practice? __________ Which of the following best describes your primary area of medical specialty? o Clinical microbiology o Infectious diseases (adults) o Infectious diseases (pediatric) o Internal medicine o Other How many years have you been registered as a consultant (i.e. medical specialist)? o Still in training for consultant o 0-10 years o 11-20 years o 21-30 years o More than 30 years The following question refers to MSSA bacteremia What is your first-choice initial antibiotic regimen in patients with confirmed monobacterial MSSA bacteremia without implanted prosthetic material provided the isolate is susceptible to the drug? □ Aminoglycoside, e.g. gentamicin □ Anti-staphylococcal penicillin, e.g. flucloxacillin dicloxacillin □ Carbapenem, e.g. meropenem □ Clindamycin □ First-generation cephalosporin, e.g. cefazolin □ Second-generation cephalosporin, e.g. cefuroxime □ Third-generation cephalosporin, e.g. ceftriaxone □ Fourth-generation cephalosporin, e.g. cefepime □ Fifth generation cephalosporin, i.e. ceftaroline □ Fluoroquinolone, e.g. levofloxacin □ Glycopeptide, e.g. vancomycin □ Linezolid □ Lipopeptide, e.g. daptomycin □ Piperacillin/tazobactam □ Rifampicin □ Trimethoprim/sulfamethoxazole □ Other
RkJQdWJsaXNoZXIy MTk4NDMw